SARS-CoV-2 viral dynamics in non-human primates

A Gonçalves, P Maisonnasse, F Donati… - PLoS computational …, 2021 - journals.plos.org
A Gonçalves, P Maisonnasse, F Donati, M Albert, S Behillil, V Contreras, T Naninck, R Marlin
PLoS computational biology, 2021journals.plos.org
Non-human primates infected with SARS-CoV-2 exhibit mild clinical signs. Here we used a
mathematical model to characterize in detail the viral dynamics in 31 cynomolgus macaques
for which nasopharyngeal and tracheal viral load were frequently assessed. We identified
that infected cells had a large burst size (> 104 virus) and a within-host reproductive basic
number of approximately 6 and 4 in nasopharyngeal and tracheal compartment,
respectively. After peak viral load, infected cells were rapidly lost with a half-life of 9 hours …
Non-human primates infected with SARS-CoV-2 exhibit mild clinical signs. Here we used a mathematical model to characterize in detail the viral dynamics in 31 cynomolgus macaques for which nasopharyngeal and tracheal viral load were frequently assessed. We identified that infected cells had a large burst size (>104 virus) and a within-host reproductive basic number of approximately 6 and 4 in nasopharyngeal and tracheal compartment, respectively. After peak viral load, infected cells were rapidly lost with a half-life of 9 hours, with no significant association between cytokine elevation and clearance, leading to a median time to viral clearance of 10 days, consistent with observations in mild human infections. Given these parameter estimates, we predict that a prophylactic treatment blocking 90% of viral production or viral infection could prevent viral growth. In conclusion, our results provide estimates of SARS-CoV-2 viral kinetic parameters in an experimental model of mild infection and they provide means to assess the efficacy of future antiviral treatments.
PLOS